Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-61.35	45.48	117.67
Graham Fair Price	-56.64	12.10	27.90
PEG	2954.82	0.84	-0.03
Price/Book	-4.63	1.44	1.51
Price/Cash Flow	-82.65	-69.01	397.71
Prices/Earnings	-411.77	-68.03	-13.29
Price/Sales	-8.69	2.71	2.97
Price/FCF	-82.65	-69.01	397.71
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	33.28	0.17	0.13
Operating Margin	-51.50	0.02	-0.03
ROA	81.02	< 0.005	-0.01
ROE	-0.03	< 0.005	81.37
ROIC	-0.02	< 0.005	71.40
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.01	-0.08	-82.17
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-2.43	1.51	-37.78
EPS QOQ	-4.82	0.81	-83.25
FCF QOQ	-0.92	-6.52	-609.60
Revenue QOQ	-0.06	0.05	-21.22
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	75.95	82.07	8.06
Days Sales Outstanding (DSO)	65.93	65.77	-0.24
Inventory Turnover	1.19	1.10	-7.46
Debt/Capitalization	0.29	0.34	15.92
Quick Ratio	0.94	0.99	5.65
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	34.92	35.07	0.44
Cash	3.38	3.95	16.77
Capex	-1.61	-0.56	65.13
Free Cash Flow	0.13	-0.73	452.00
Revenue	17.73	18.60	4.90
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.77	1.78	1.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	25.60	10.20	-60.14
Naive Interpretation	Member

06 - Financial Health · Weak

Rating